US Stock MarketDetailed Quotes

Cue Biopharma (CUE)

Watchlist
  • 0.3010
  • +0.0012+0.40%
Close Mar 9 16:00 ET
  • 0.3160
  • +0.0150+4.98%
Post 20:01 ET
27.46MMarket Cap-0.73P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cue Biopharma (CUE) Revenue Breakdown Overview

By Business/Source

Currency:USD
2025/Q3
Stock NameRevenueRatio
Developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells2.15M100.00%

By Country/Region

Currency:USD
2024/FY
Stock NameRevenueRatio
United States9.29M100.00%
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.62%
Sample Name
Sample Code
 +3.13%
Sample Name
Sample Code
 +2.72%
4
Alphabet-A
GOOGL
+2.70%
5
Qualcomm
QCOM
+1.78%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.31%
Sample Name
Sample Code
 +8.59%
Sample Name
Sample Code
 +4.66%
4
Trip.com
TCOM
+4.39%
5
JD.com
JD
+4.25%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the ongoing conflict between the US and Iran has continued to unsettle the stock market. However, the latest reports suggest that Show More
Breaking! The US and Israel jointly bombed Iran. What will be the stock market trend next week?
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

- No more -